Mar 8, 2012Company gains first and only commercially available subcutaneous ICD technology to offer lifesaving therapy to patients at risk of sudden cardiac arrest
Boston Scientific Corporation (NYSE: BSX) announces the exercise of its option to acquire Cameron Health, Inc., a privately held company based in San Clemente, California. Cameron Health has...
Feb 25, 2012Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal Stent Deformation With Boston Scientific Platinum Chromium StentsQuantitative Coronary Angiographic outcomes from PERSEUS and PLATINUM clinical trials presented at ACC 2012
Boston Scientific Corporation (NYSE: BSX) announces results from a quantitative coronary angiographic (QCA) analysis of the incidence of longitudinal stent deformation in the PERSEUS and PLATINUM...
Feb 2, 2012Boston Scientific annuncia il primo impianto e la commercializzazione in Europa dello Stent Promus Element™ PlusLo stent coronarico in platino e cromo con un sistema avanzato di delivery è adesso disponibile in Europa e in altri Paesi
Boston Scientific Corporation (NYSE: BSX) ha annunciato oggi il primo impianto supaziente e la commercializzazione in Europa dello stent coronarico in platino e cromo a rilascio di Everolimus,...
Feb 1, 2012Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in EuropePlatinum chromium coronary stent with enhanced delivery system now available in Europe and other international countries
Boston Scientific Corporation (NYSE: BSX) announces first patient use and European market launch of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System. The first...
Jan 26, 2012NICE Report Supports Safety and Effectiveness of Alair® System
Boston Scientific (UK) welcomes new guidance from the National Institute for Health and Clinical Excellence (NICE) on the use of Bronchial Thermoplasty (BT) to treat adult patients with severe...